Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

for
Prostate Cancer
Location: Baltimore MD, New York NY, Seattle WA
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 18+

Code: NCT04995198

Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for
Hidradenitis Suppurativa (HS)
Location: Rockville MD, Baltimore MD, Richmond VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06855498

Phase 3, Recruiting

Synbiotic Compound to Reduce Symptoms of Schizophrenia

for
Schizophrenia, Schizoaffective Disorder
Location: Batlimore MD
Sponsor: Sheppard Pratt Health System

Sex: All

Age: 18 - 65

Code: NCT04226898

Phase 2, Recruiting

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Baltimore MD, The Bronx NY, New Haven CT, Columbus OH,
Sponsor: DynamiCure Biotechnology

Sex: All

Age: 18+

Code: NCT05785754

Phase 1, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Washington D.C. DC, Annapolis MD, Baltimore MD,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

for
Hepatocellular Carcinoma, Biliary Tract Cancer
Location: Baltimore MD, Philadelphia PA, Pittsburgh PA,
Sponsor: Replimune Inc.

Sex: All

Age: 18+

Code: NCT05733598

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Washington D.C. DC, Hyattsville MD, Charlotte NC,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05894239

Phase 3, Recruiting

Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

for
Oropharyngeal Cancers, HPV, Tonsil Cancer,
Location: Washington D.C. DC, Clinton MD
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06902623

Recruiting

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

for
Breast Reconstruction Surgery
Location: Baltimore MD, Philadelphia PA, New York NY,
Sponsor: W.L.Gore & Associates

Sex: Female

Age: 22+

Code: NCT06556654

Recruiting

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

for
Pancreatic Cyst
Location: Baltimore MD, New York NY, Garden City NY, New Haven CT,
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT03492151

Recruiting

Platform of Randomized Adaptive Clinical Trials in Critical Illness

for
Respiratory Insufficiency,
Location: Baltimore MD, Philadelphia PA, Norfolk VA,
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05440851

Recruiting

Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries

for
Pressure Ulcers Stage II, Pressure Ulcers Stage III,
Location: Washington D.C. DC, Baltimore MD, Pittsburgh PA,
Sponsor: ULURU Inc.

Sex: All

Age: 18 - 70+

Code: NCT05496296

Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Silver Spring MD, Baltimore MD, Hershey PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase 3, Recruiting

Optimal Pacing Rate for Cardiac Resynchronization Therapy

for
Atrial Fibrillation, Persistent
Location: Washington DC, Fairfax VA, Clinton MD
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06445439

Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors That Are MTAP Deficient
Location: Fairfax VA, Baltimore MD, Pittsburgh PA, New Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06130553

Phase 1, Phase 2, Recruiting

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Washington D.C. DC, Hanover MD, Annapolis MD,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase 3, Recruiting

TruGraf® Long-term Clinical Outcomes Study

for
Kidney Transplant Rejection
Location: Washington DC, Falls Church VA, Baltimore MD,
Sponsor: Transplant Genomics, Inc.

Sex: All

Age: 18+

Code: NCT04491552

Recruiting

Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1

for
Radiation-Induced Xerostomia and Hyposalivation
Location: Baltimore MD, Philadelphia PA, New York NY,
Sponsor: RiboX Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06714253

Phase 1, Phase 2, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Washington D.C. DC, Baltimore MD, Somerville NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase 2, Phase 3, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Charlottesville VA,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting